What is the ROCE (Return on Capital Employed) of MDxHealth this year?
The ROCE of MDxHealth is -4.07 undefined this year.
MDxHealth ROCE 2024
MDxHealth ROCE
-4.07
Ticker
MDXH.BR
ISIN
BE0003844611
WKN
A0J3N3
In 2024, MDxHealth's return on capital employed (ROCE) was -4.07, a 611.36% increase from the -0.57 ROCE in the previous year.
MDxHealth Aktienanalyse
What does MDxHealth do?
MDxHealth SA was founded in 2003 and is a publicly traded company based in Belgium, specializing in the development and marketing of molecular diagnostic tests for cancer diagnosis. The company focuses on developing tests for the diagnosis of prostate, bladder, and kidney cancer, as well as tests for monitoring the progression of these cancer types. The business model of MDxHealth is to develop state-of-the-art molecular diagnostics for cancer medicine and make them accessible to medical professionals and pathologists. The company has a strong presence in the US and Europe, and works closely with leading cancer centers and clinics to promote the use of the tests and improve their effectiveness. MDxHealth also provides support to its customers in interpreting test results and choosing the best treatment options for patients. The company has different divisions tailored to the specific needs of patients, doctors, and pathologists. The main divisions are the oncology division and the urology division. In the oncology division, MDxHealth offers various tests for prostate cancer, including the Prognostic Oncotype DX Test used for predicting the progression of prostate cancer. The urology division of MDxHealth focuses on developing tests for bladder cancer and kidney cancer. The key tests in this division include the ConfirmMDx Test used for diagnosing bladder cancer, and the SelectMDx Test used for diagnosing aggressive prostate cancer. MDxHealth also has a significant presence in genomics and personalized medicine. The company partners with the University of Miami Miller School of Medicine to research and improve the application of genetic tests in cancer diagnosis and treatment. MDxHealth also collaborates closely with other leading research institutions and cancer centers to drive innovation in molecular diagnostics. Overall, MDxHealth offers a wide range of molecular diagnostic tests for cancer diagnosis and monitoring. The company has a strong presence in the US and Europe, and works closely with leading cancer centers and clinics to promote the use of the tests and improve their effectiveness. MDxHealth is a key player in the field of molecular diagnostics and has the potential to improve the lives of cancer patients worldwide. MDxHealth ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling MDxHealth's Return on Capital Employed (ROCE)
MDxHealth's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing MDxHealth's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
MDxHealth's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in MDxHealth’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about MDxHealth stock
How has the ROCE (Return on Capital Employed) of MDxHealth developed compared to the previous year?
The ROCE of MDxHealth has increased by 611.36% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of MDxHealth?
A high Return on Capital Employed (ROCE) indicates that MDxHealth has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of MDxHealth?
A low ROCE (Return on Capital Employed) can indicate that MDxHealth has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from MDxHealth impact the company?
An increase in the ROCE of MDxHealth can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of MDxHealth affect the company?
A decrease in ROCE of MDxHealth can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of MDxHealth?
Some factors that can affect MDxHealth's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of MDxHealth so important for investors?
The ROCE of MDxHealth is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can MDxHealth take to improve the ROCE?
To improve the ROCE, MDxHealth can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does MDxHealth pay?
Over the past 12 months, MDxHealth paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MDxHealth is expected to pay a dividend of 0 USD.
What is the dividend yield of MDxHealth?
The current dividend yield of MDxHealth is .
When does MDxHealth pay dividends?
MDxHealth pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MDxHealth?
MDxHealth paid dividends every year for the past 0 years.
What is the dividend of MDxHealth?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is MDxHealth located?
MDxHealth is assigned to the 'Health' sector.
Wann musste ich die Aktien von MDxHealth kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MDxHealth from 10/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2024.
When did MDxHealth pay the last dividend?
The last dividend was paid out on 10/8/2024.
What was the dividend of MDxHealth in the year 2023?
In the year 2023, MDxHealth distributed 0 USD as dividends.
In which currency does MDxHealth pay out the dividend?
The dividends of MDxHealth are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von MDxHealth
Our stock analysis for MDxHealth Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MDxHealth Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
